(Q37769427)

22 August 2017

1 reference

title

Improvement of visual acuity in patients with severe visual loss affected by multiple sclerosis treated with natalizumab: a case report (English)

1 reference

22 August 2017

0 references

Ciro Florio

1

1 reference

22 August 2017

Giorgia Teresa Maniscalco

series ordinal

2

1 reference

22 August 2017

publication date

1 January 2011

1 reference

22 August 2017

published in

Neurological Sciences

1 reference

22 August 2017

volume

31 Suppl 3

1 reference

22 August 2017

page(s)

325-327

1 reference

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0349-7

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0349-7

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0349-7

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0349-7

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20596742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20596742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10072-010-0349-7

1 reference

release_7mmqhpwfqrgp7eqe7plgy7o44m

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7mmqhpwfqrgp7eqe7plgy7o44m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference